Human medicines European public assessment report (EPAR): Zessly, infliximab, Arthritis, Psoriatic;Psoriasis;Crohn Disease;Arthritis, Rheumatoid;Colitis, Ulcerative;Spondylitis, Ankylosing, Date of authorisation: 18/05/2018, Revision: 12, Status: Authori

Human medicines European public assessment report (EPAR): Zessly, infliximab, Arthritis, Psoriatic;Psoriasis;Crohn Disease;Arthritis, Rheumatoid;Colitis, Ulcerative;Spondylitis, Ankylosing, Date of authorisation: 18/05/2018, Revision: 12, Status: Authorised